ClinicalTrials.gov

History of Changes for Study: NCT02513043
Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
Latest version (submitted February 3, 2022) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 July 30, 2015 None (earliest Version on record)
2 August 4, 2015 Study Design and Study Status
3 March 8, 2016 Study Status
4 August 5, 2016 Recruitment Status, Study Status, Contacts/Locations and Oversight
5 May 10, 2017 Study Status, Contacts/Locations and Study Design
6 October 27, 2017 Study Status and Contacts/Locations
7 May 22, 2018 Study Status and Contacts/Locations
8 May 31, 2018 Contacts/Locations and Study Status
9 April 2, 2019 Study Status, Contacts/Locations and Eligibility
10 July 30, 2020 Study Status, Contacts/Locations and Study Design
11 February 3, 2022 Recruitment Status, Study Status, Contacts/Locations and Study Design
Comparison Format:

Scroll up to access the controls

Study NCT02513043
Submitted Date:  May 10, 2017 (v5)

Open or close this module Study Identification
Unique Protocol ID: 1031
Brief Title: Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
Official Title: Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
Secondary IDs:
Open or close this module Study Status
Record Verification: May 2017
Overall Status: Recruiting
Study Start: March 22, 2016
Primary Completion: June 2018 [Anticipated]
Study Completion: June 2018 [Anticipated]
First Submitted: July 24, 2015
First Submitted that
Met QC Criteria:
July 30, 2015
First Posted: July 31, 2015 [Estimate]
Last Update Submitted that
Met QC Criteria:
May 10, 2017
Last Update Posted: May 11, 2017 [Actual]
Open or close this module Sponsor/Collaborators
Sponsor: Gynuity Health Projects
Responsible Party: Sponsor
Collaborators:
Open or close this module Oversight
U.S. FDA-regulated Drug:
U.S. FDA-regulated Device:
Data Monitoring: No
Open or close this module Study Description
Brief Summary: This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.
Detailed Description: The objective of this pilot study is to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.
Open or close this module Conditions
Conditions: Pregnancy
Keywords:
Open or close this module Study Design
Study Type: Observational
Observational Study Model: Case-Only
Time Perspective: Prospective
Biospecimen Retention:
Biospecimen Description:
Enrollment: 1000 [Anticipated]
Number of Groups/Cohorts 0
Open or close this module Groups and Interventions
Intervention Details:
Drug: medical abortion
medical abortion
Open or close this module Outcome Measures
Primary Outcome Measures:
1. Number of participants with adverse events as a measure of safety and tolerability
[ Time Frame: 1 year ]

adverse events
Open or close this module Eligibility
Study Population: Women seeking abortion
Sampling Method: Non-Probability Sample
Minimum Age: 11 Years
Maximum Age: 50 Years
Sex: Female
Gender Based:
Accepts Healthy Volunteers: Yes
Criteria:

Inclusion Criteria:

  • desires abortion

Exclusion Criteria:

  • medically ineligible for procedure
Open or close this module Contacts/Locations
Study Officials: Erica Chong, MPH
Principal Investigator
Gynuity Health Projects
Elizabeth Raymond, MD, MPH
Principal Investigator
Gynuity Health Projects
Locations: United States, Hawaii
The University of Hawaii Women's Options Centers
[Recruiting]
Honolulu, Hawaii, United States, 96826
Contact:Contact: Mary Tschann, MPH 808-203-6561
Contact:Principal Investigator: Bliss Kaneshiro, MD, MPH
United States, Maine
Maine Family Planning
[Not yet recruiting]
Augusta, Maine, United States
Contact:Contact: Shannon Mackey 207-248-3924
Contact:Principal Investigator: Leah Coplon, MPH, RN
United States, New York
Choices Women's Medical Center
[Active, not recruiting]
Jamaica, New York, United States, 11435
United States, Oregon
Oregon Health and Sciences University Women's Health Research Unit
[Recruiting]
Portland, Oregon, United States, 97239
Contact:Contact: Ariela Schyner 503-494-3959
Contact:Principal Investigator: Maureen Baldwin, MD
Open or close this module IPDSharing
Plan to Share IPD:
Open or close this module References
Citations:
Links:
Available IPD/Information:

Scroll up to access the controls Scroll to the Study top

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services